Brian M. Stolz serves as Executive at Valeant Pharmaceuticals International, Inc., where they oversee executive responsibilities. Since joining the company, Brian M. Stolz has executed 51 insider transactions totaling $7.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 9, 2011 involved purchasing 750 shares valued at $29.3K.
Brian M. Stolz currently holds 24,615 shares of Valeant Pharmaceuticals International, Inc. (VRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian M. Stolz has been a net seller of VRX stock. They have purchased $1.1M and sold $6.4M worth of shares.
Brian M. Stolz's most recent insider trade was on Aug 9, 2011, when they purchased 750 shares at $39.10 per share.
Get notified when new Form 4 filings are submitted